Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

941 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous 60-day peripheral nerve stimulation implant provides sustained relief of chronic pain following amputation: 12-month follow-up of a randomized, double-blind, placebo-controlled trial.
Gilmore CA, Ilfeld BM, Rosenow JM, Li S, Desai MJ, Hunter CW, Rauck RL, Nader A, Mak J, Cohen SP, Crosby ND, Boggs JW. Gilmore CA, et al. Among authors: mak j. Reg Anesth Pain Med. 2019 Nov 17:rapm-2019-100937. doi: 10.1136/rapm-2019-100937. Online ahead of print. Reg Anesth Pain Med. 2019. PMID: 31740443
Percutaneous peripheral nerve stimulation for the treatment of chronic neuropathic postamputation pain: a multicenter, randomized, placebo-controlled trial.
Gilmore C, Ilfeld B, Rosenow J, Li S, Desai M, Hunter C, Rauck R, Kapural L, Nader A, Mak J, Cohen S, Crosby N, Boggs J. Gilmore C, et al. Among authors: mak j. Reg Anesth Pain Med. 2019 Jun;44(6):637-645. doi: 10.1136/rapm-2018-100109. Epub 2019 Apr 5. Reg Anesth Pain Med. 2019. PMID: 30954936 Clinical Trial.
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers.
Mak J, Khan S, Britton A, Rose S, Gwynn L, Ellingson KD, Meece J, Feldstein L, Tyner H, Edwards L, Thiese MS, Naleway A, Gaglani M, Solle N, Burgess JL, Lamberte JM, Shea M, Hunt-Smith T, Caban-Martinez A, Porter C, Wiegand R, Rai R, Hegmann KT, Hollister J, Fowlkes A, Wesley M, Philips AL, Rivers P, Bloodworth R, Newes-Adeyi G, Olsho LEW, Yoon SK, Saydah S, Lutrick K. Mak J, et al. J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093/infdis/jiae556. Online ahead of print. J Infect Dis. 2024. PMID: 39531735
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023.
Ciesla AA, Mak J, Roper LE, Fleming-Dutra KE, Smith ZR, Wiegand RE, Britton A, Miller J, Link-Gelles R. Ciesla AA, et al. Among authors: mak j. Influenza Other Respir Viruses. 2024 Nov;18(11):e70038. doi: 10.1111/irv.70038. Influenza Other Respir Viruses. 2024. PMID: 39522959 Free PMC article.
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study.
White EB, Grant L, Mak J, Olsho L, Edwards LJ, Naleway A, Burgess JL, Ellingson KD, Tyner H, Gaglani M, Lutrick K, Caban-Martinez A, Newes-Adeyi G, Duque J, Yoon SK, Phillips AL, Thompson M, Britton A, Flannery B, Fowlkes A. White EB, et al. Among authors: mak j. Clin Infect Dis. 2024 Oct 24:ciae491. doi: 10.1093/cid/ciae491. Online ahead of print. Clin Infect Dis. 2024. PMID: 39446477
941 results